Correlation Between Microsoft and Royalty Pharma
Can any of the company-specific risk be diversified away by investing in both Microsoft and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Royalty Pharma Plc, you can compare the effects of market volatilities on Microsoft and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Royalty Pharma.
Diversification Opportunities for Microsoft and Royalty Pharma
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Royalty is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Microsoft i.e., Microsoft and Royalty Pharma go up and down completely randomly.
Pair Corralation between Microsoft and Royalty Pharma
Given the investment horizon of 90 days Microsoft is expected to generate 1.08 times more return on investment than Royalty Pharma. However, Microsoft is 1.08 times more volatile than Royalty Pharma Plc. It trades about 0.02 of its potential returns per unit of risk. Royalty Pharma Plc is currently generating about 0.01 per unit of risk. If you would invest 41,449 in Microsoft on September 2, 2024 and sell it today you would earn a total of 897.00 from holding Microsoft or generate 2.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Royalty Pharma Plc
Performance |
| Timeline |
| Microsoft |
| Royalty Pharma Plc |
Microsoft and Royalty Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Royalty Pharma
The main advantage of trading using opposite Microsoft and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |